Aurora Spine

60 articles about Aurora Spine

• Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call

  8/22/2022

  Aurora Spine Corporation today announced it will issue its financial results press release for the second quarter ended June 30, 2022, on Monday, August 29, 2022.

• Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants

  7/12/2022

  Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication for Use for its ZIP™ family of MIS implants.

• Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion

  6/13/2022

  Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No: 11,331,199 entitled "Spinal Implant for Motion Preservation or Fusion."

• Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform

  6/6/2022

  Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced that it had received FDA 510 clearance for its DEXA SOLO-L™ spinal fusion system.

• Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call

  5/23/2022

  Aurora Spine Corporation today announced it will issue its financial results press release for the first quarter ended March 31, 2022, on Monday May 23, 2022.

• Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference

  3/31/2022

  Aurora Spine Corporation, a manufacturer of innovative spinal implants, announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.

• Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device

  3/3/2022

  Aurora Spine Corporation, a manufacturer of innovative spinal implants announced that it has completed the world’s first DEXA-C implantation at Cypress Pointe Surgical Hospital in Louisiana, where the implant density was directly matched with the patient’s bone quality.

• Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical

  2/24/2022

  Aurora Spine Corporation announced today that it has entered into a joint co-marketing agreement with Echolight Medical, a manufacturer of the radiation-free EchoS portable densitometer used for patient assessment of bone mineral density (BMD) and the quality of bone microarchitecture independent of BMD.

• Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 2021- Company experiencing improved sales momentum from proprietary products -

  2/22/2022

  Aurora Spine Corporation today announced a business update for investors and preliminary, unaudited revenue results for the fourth quarter and fiscal year ended December 31, 2021.

• Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion- New Patent will Strengthen Company’s IP Portfolio -

  2/7/2022

  Aurora Spine Corporation announced today that it has received “Notice of Allowance” for its patent from the United States Patent and Trademark Office (USPTO), for the invention: ‘Spinal Implant for Motion Preservation or Fusion’.

• Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate

  1/25/2022

  Aurora Spine Corporation announced today that the first anterior cervical discectomy and fusion procedures were completed with its proprietary APOLLO TM Anterior Cervical Plate (ACP) system.

• Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage

  12/21/2021

  Aurora Spine Corporation announced today that a Peer-Reviewed Clinical Publication titled ‘Improving the Management of Patients with Osteoporosis Undergoing Spinal Fusion.

• Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference

  12/7/2021

  Aurora Spine Corporation announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December 13-16, 2021.

• Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products

  12/2/2021

  Aurora Spine Corporation today announced it has retained PRIA Healthcare to assist in patient access for its proprietary products, including ZIP® and SiLO.

• Aurora Spine Corporation to Present at the Lytham Partners Fall 2021 Investor Conference

  10/1/2021

  Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced it will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7.

• Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

  9/27/2021

  Aurora Spine Corporation today announced it would be participating at the 2021 North American Spine Society ("NASS") Annual Meeting, September 29-October 2, 2021 at the Boston Convention Center in Boston, Massachusetts at Booth #1925.

• Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors

  9/15/2021

  Aurora Spine Corporation today announced that it has entered into securities purchase agreements for a private placement of the Company’s common shares

• Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device

  8/10/2021

  Aurora Spine Corporation today announced that the first patients have been enrolled into a pivotal multi-center study of its ZIP® Interspinous Fixation device for patients suffering from back pain due to symptomatic degenerative disc disease.

• Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System

  8/3/2021

  Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced it had received U.S. Food and Drug Administration 510 Clearance for its DEXA-C, a new line of cervical cages for anterior cervical discectomy with fusion procedures.

• Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference

  7/28/2021

  Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced its management team will be participating in Alliance Global Partners’ Virtual MedTech Summer Conference on Thursday, July 29, 2021.